Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.
Source: https://www.zacks.com/commentary/2878485/3-generic-drug-stoc…
In 2026, Wall Street’s attitude towards AI changed to fears over the tech’s negative ramifications. Share prices fell for excellent AI-focused businesses, such as Alphabet and Symbotic.
As of Jan. 12, 2026, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Inflation has negatively impacted consumer staples companies. Conagra stock has lost 50% of its value over the last three years.
